VOLITIONRX LTD — Director's Dealing 2014

Jan 27, 2014

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2013-12-31

Reporting Person: Colman Alan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-16	Common Stock	A	3112	$2.25	Acquired	50755	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrant	$0.5	2016-04-01	Common Stock (100000)	100000	Direct
Option	$3	2015-05-25	Common Stock (5000)	5000	Direct
Option	$3	2015-11-25	Common Stock (5000)	5000	Direct
Option	$4	2016-05-25	Common Stock (5000)	5000	Direct
Option	$4	2016-11-25	Common Stock (5000)	5000	Direct
Option	$5	2017-05-25	Common Stock (5000)	5000	Direct
Option	$5	2017-11-25	Common Stock (5000)	5000	Direct
Warrant	$2.6	2016-05-10	Common Stock (13000)	13000	Direct

Footnotes

F1: On August 16, 2013, Dr. Alan Coleman received 3,112 shares of the Company's common stock with a cost basis of $2.25 per share, as settlement for certain debts owed to Dr. Coleman by the Company.